Iliomad Health Data

Privacy Solutions for Life Sciences

We provide data privacy compliance services for Healthcare, Pharmaceutical and Healthtech companies.

Tailor-Made Services

We help Life Sciences companies build their privacy compliance systems.

Privacy Officer and Representative

iliomad Health Data provides specialized Privacy Officers for the Life Sciences industry. Our DPOs are certified CDPO and ISO 27005 Risk management. We offer specialized services for a special industry.

Training and Awareness

In the context of compliance with the GDPR, HIPAA, CCPA, Swiss FADP, and other regulations, knowledge is indeed the key. We have crafted distinct training programs, specifically designed for Life Sciences companies, that cater to various data protection regulations.

Policies and Procedures

We assist in the creation of comprehensive, written policies and procedures that clearly convey your organization's dedication to adhering to data protection laws. Our services encompass the development of policies related to data collection, processing, storage, sharing, and destruction.

Risk Analysis

Our team of experts is committed to helping your organization identify, assess, and prioritize the risks associated with the handling of sensitive data. iliomad Health Data guides life sciences companies through each step of the risk analysis process, ensuring that they are fully equipped to make informed decisions and maintain compliance with relevant data protection regulations.


Our expertise encompasses the European Union, United Kingdom, and United States, ensuring comprehensive compliance for your company.

Latest Resources

The latest industry news, articles, and best practices from our team.

May 1, 2024

Newsletter #13

April 2024 will go down in history as the month when the first federal privacy bill was introduced. Additionally, April witnessed the integration of AI into biotech, revolutionizing traditional biotech at Tech Bios. Also, don't forget to check out our podcast selection that explores AI and its applications in digital pathology, among other topics.

April 1, 2024

Newsletter #12

Happy Easter! March turned out to be a notable month for AI, breaking the mold of the past year. The EU Parliament has officially passed the EU Act, NVIDIA has made significant announcements, and there have been substantial advancements in health data utilization. We're constantly enhancing our offerings, so don't forget to explore our most recent interview, recommended podcasts, and book recommendations!

March 1, 2024

Newsletter #11

As we kick off 2024, the eleventh edition of our newsletter zeroes in on the most recent developments in privacy regulations and guidelines. It also spotlights the latest happenings in the Biotech and Healthtech sectors related to data. Don't miss our podcast recommendations, featuring an enlightening interview with OWKIN's CEO and a compelling discussion on the intersection of developers and privacy. Enjoy!